PL2471512T3 - Formulacje niepolarnych fotouczulaczy do terapii fotodynamicznej - Google Patents

Formulacje niepolarnych fotouczulaczy do terapii fotodynamicznej

Info

Publication number
PL2471512T3
PL2471512T3 PL12161556T PL12161556T PL2471512T3 PL 2471512 T3 PL2471512 T3 PL 2471512T3 PL 12161556 T PL12161556 T PL 12161556T PL 12161556 T PL12161556 T PL 12161556T PL 2471512 T3 PL2471512 T3 PL 2471512T3
Authority
PL
Poland
Prior art keywords
formulations
photodynamic therapy
photosensitizers
polar
polar photosensitizers
Prior art date
Application number
PL12161556T
Other languages
English (en)
Inventor
Volker Albrecht
Alfred Fahr
Dietrich Scheglmann
Susanna Gräfe
Wolfgang Neuberger
Original Assignee
Biolitec Unternehmensbeteilligungs Ll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biolitec Unternehmensbeteilligungs Ll Ag filed Critical Biolitec Unternehmensbeteilligungs Ll Ag
Publication of PL2471512T3 publication Critical patent/PL2471512T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL12161556T 2003-08-26 2004-06-23 Formulacje niepolarnych fotouczulaczy do terapii fotodynamicznej PL2471512T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/648,168 US20050048109A1 (en) 2003-08-26 2003-08-26 Non-polar photosensitizer formulations for photodynamic therapy
EP04776989A EP1660041B1 (en) 2003-08-26 2004-06-23 Non-polar photosensitizer formulations for photodynamic therapy
EP12161556.1A EP2471512B1 (en) 2003-08-26 2004-06-23 Non-polar photosensitizer formulations for photodynamic therapy

Publications (1)

Publication Number Publication Date
PL2471512T3 true PL2471512T3 (pl) 2016-08-31

Family

ID=34216686

Family Applications (2)

Application Number Title Priority Date Filing Date
PL04776989T PL1660041T3 (pl) 2003-08-26 2004-06-23 Niepolarne formulacje fotosensybilizatora
PL12161556T PL2471512T3 (pl) 2003-08-26 2004-06-23 Formulacje niepolarnych fotouczulaczy do terapii fotodynamicznej

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL04776989T PL1660041T3 (pl) 2003-08-26 2004-06-23 Niepolarne formulacje fotosensybilizatora

Country Status (16)

Country Link
US (3) US20050048109A1 (pl)
EP (2) EP2471512B1 (pl)
JP (2) JP4869929B2 (pl)
KR (3) KR100975160B1 (pl)
CN (1) CN1842322B (pl)
AU (1) AU2004270119B2 (pl)
BR (1) BRPI0413889A (pl)
CA (2) CA2746516C (pl)
DK (2) DK2471512T3 (pl)
ES (2) ES2566681T3 (pl)
HU (1) HUE026790T2 (pl)
IL (2) IL173808A (pl)
PL (2) PL1660041T3 (pl)
PT (1) PT1660041E (pl)
RU (1) RU2343904C2 (pl)
WO (1) WO2005023220A1 (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7968115B2 (en) 2004-03-05 2011-06-28 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of cancer
US20050048109A1 (en) * 2003-08-26 2005-03-03 Ceramoptec Industries, Inc. Non-polar photosensitizer formulations for photodynamic therapy
US8986731B2 (en) * 2003-08-26 2015-03-24 Biolitec Pharma Marketing Ltd Pegylated liposomal formulations of hydrophobic photosensitizers for photodynamic therapy
US8784881B2 (en) * 2004-03-05 2014-07-22 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of diseases
US20080103213A1 (en) * 2004-03-05 2008-05-01 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of neurofibromatosis
US20090297592A1 (en) * 2005-05-11 2009-12-03 Jcr Pharmaceuticals Co., Ltd. Lipid Vesicle Composition
US20070031482A1 (en) * 2005-08-02 2007-02-08 Ceramoptec Industries, Ind. PDT treatment method for cellulites and cosmetic use
US8999933B2 (en) * 2006-01-18 2015-04-07 Biolitec Pharma Marketing Ltd Photodynamic cosmetic procedure and healing method
TW200738278A (en) * 2006-04-03 2007-10-16 Univ Taipei Medical A liposome combination and the use thereof
US20090081281A1 (en) * 2006-05-10 2009-03-26 Gerard Farmer Photosensitizer Formulation for Topical Applications
US20080275432A1 (en) * 2006-05-11 2008-11-06 Ceramoptec Industries, Inc. Photodynamic foam composition and sclerosis treatment
EP2034963B1 (en) * 2006-05-18 2022-08-10 biolitec Unternehmensbeteiligungs II AG Gel-formulations of hydrophobic photosensitizers for mucosal applications
CZ2006743A3 (cs) * 2006-11-28 2008-03-26 Fyziologický ústav AV CR Liposomální gelový ftalocyaninový prípravek pro fotodynamickou terapii nádorových onemocnení a zpusob jeho prípravy
US20090162423A1 (en) * 2007-12-20 2009-06-25 Ceramoptec Industries, Inc. Formulations for cosmetic and wound care treatments with photosensitizes as fluorescent markers
WO2008088037A1 (ja) * 2007-01-18 2008-07-24 National University Corporation Chiba University 微粒子製剤
US20080214460A1 (en) * 2007-01-18 2008-09-04 Ceramoptec Industries, Inc. Formulations for cosmetic and wound care treatments with photosensitizers as fluorescent markers
WO2009067217A1 (en) * 2007-11-20 2009-05-28 Ceramoptec Industries, Inc. Pdt assisted scar prevention and vision correction
ES2707228T3 (es) 2008-09-18 2019-04-03 Biolitec Unternehmensbeteiligungs Ii Ag Nuevo método y aplicación de porfirinas y clorinas asimétricamente meso-sustituidas para TFD
US8815931B2 (en) * 2009-04-28 2014-08-26 Biolitec Pharma Marketing Ltd Oral formulations for tetrapyrrole derivatives
US20110275686A1 (en) * 2009-12-11 2011-11-10 Biolitec, Inc. Nanoparticle carrier systems based on poly(dl-lactic-co-glycolic acid) (plga) for photodynamic therapy (pdt)
RU2428981C1 (ru) * 2010-03-31 2011-09-20 Анатолий Юрьевич Барышников Средство для фотодинамической терапии, способ получения предлагаемого средства и способ проведения фотодинамической терапии с использованием предлагаемого средства
RU2446842C2 (ru) * 2010-07-15 2012-04-10 Учреждение Российской академии наук Центральная клиническая больница РАН Способ лечения местнораспространенных онкологических заболеваний в эксперименте
CN102432755B (zh) * 2011-09-05 2013-11-13 苏州大学 多重靶向性的光动力学疗法聚合物载体及其制备方法
US10117942B2 (en) 2013-07-12 2018-11-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Photoactivatable lipid-based nanoparticles as vehicles for dual agent delivery
US10456375B2 (en) 2014-09-30 2019-10-29 Biolitec Unternehmensbeteiligungs Ii Ag Specifically meso-substituted porphyrins and chlorins for photodynamic therapy
JP5995207B2 (ja) * 2014-11-28 2016-09-21 学校法人 学習院 含ホウ素ポルフィリン誘導体
CN105311632A (zh) * 2015-10-27 2016-02-10 浙江大学 负载光动力治疗药物的细胞膜微囊的制备方法
ES3011714T3 (en) 2016-02-26 2025-04-08 Biolitec Holding Gmbh & Co Kg Conjugates of porphyrinoid photosensitizers and glycerol-based polymers for photodynamic therapy
CZ307681B6 (cs) 2016-02-29 2019-02-13 Ústav makromolekulární chemie AV ČR, v. v. i. Fotoaktivovatelná nanočástice pro fotodynamické aplikace, způsob její přípravy, farmaceutická kompozice ji obsahující a jejich použití
CN106421810B (zh) * 2016-09-26 2019-08-20 武汉大学 一种肿瘤靶向细胞药物载体及其应用
US12178907B2 (en) 2018-07-12 2024-12-31 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Binary lipid bilayer-containing vesicles comprising embedded cytotoxic agents and methods of making and using the same
EP3894421A1 (en) 2018-12-10 2021-10-20 Universität Hamburg Specifically glyco-substituted porphyrins and chlorins for photodynamic therapy
KR102203483B1 (ko) * 2018-12-28 2021-01-14 서울대학교산학협력단 방사성 금속 및 유로피움을 포함하는 광역동 요법용 조성물

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB214525A (en) * 1923-09-13 1924-04-24 Ella Martin Improvements in terminals for electric cables
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
IL69720A (en) * 1983-09-14 1987-08-31 Univ Ramot Anti-tumor pharmaceutical compositions comprising liposome-bound porphyrins
US5190761A (en) * 1986-08-05 1993-03-02 Liburdy Robert P Electromagnetic field triggered drug and chemical delivery via liposomes
US5162519A (en) * 1988-03-11 1992-11-10 Efamol Holdings Plc Porphyrins and cancer treatment
GB8805849D0 (en) * 1988-03-11 1988-04-13 Efamol Holdings Porphyrins & cancer treatment
JP3037994B2 (ja) * 1989-11-02 2000-05-08 テルモ株式会社 リポソーム表面への蛋白質吸着抑制剤
CA2047969A1 (en) * 1990-08-17 1992-02-18 Thomas D. Madden Benzoporphyrin vesicles
CA2087902C (en) * 1992-02-05 2006-10-17 Narendra Raghunathji Desai Liposome compositions of porphyrin photosensitizers
US6890555B1 (en) * 1992-02-05 2005-05-10 Qlt, Inc. Liposome compositions of porphyrin photosensitizers
EP0784470B1 (en) * 1994-10-03 2003-08-13 INFECTIO RECHERCHE Inc. Liposome-formulations for treatment of viral diseases
US6974666B1 (en) * 1994-10-21 2005-12-13 Appymetric, Inc. Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
US5935942A (en) * 1994-12-14 1999-08-10 Zeimer; Ran Selective and non-invasive visualization or treatment of vasculature
US5789433A (en) * 1995-01-17 1998-08-04 Quadra Logic Technologies, Inc. Green porphyrins as immunomodulators
US5707608A (en) * 1995-08-02 1998-01-13 Qlt Phototherapeutics, Inc. Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer
US5756541A (en) * 1996-03-11 1998-05-26 Qlt Phototherapeutics Inc Vision through photodynamic therapy of the eye
US6043237A (en) * 1996-12-10 2000-03-28 Qlt Phototherapeutics, Inc. Use of photodynamic therapy for prevention of secondary cataracts
NZ337693A (en) * 1997-03-10 2001-07-27 Res Dev Foundation Photodynamic therapy generated oxidative stress for temporal and selective expression of heterologous genes
US6010890A (en) * 1997-04-29 2000-01-04 New York Blood Center, Inc. Method for viral inactivation and compositions for use in same
GB9710049D0 (en) * 1997-05-19 1997-07-09 Nycomed Imaging As Method
JP4444385B2 (ja) * 1999-02-25 2010-03-31 帝人株式会社 リポソーム用時調製用キット
EP1206288B1 (en) * 1999-08-02 2007-01-10 The Regents Of The University Of Michigan Targeted fiberless radiative effectors
DE60123583T2 (de) * 2000-02-04 2007-08-09 Lipoxen Technologies Ltd. Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome
GB0005855D0 (en) * 2000-03-10 2000-05-03 Scotia Holdings Plc Compounds for pdt
AU2001258117A1 (en) * 2000-05-08 2001-11-20 The University Of British Columbia Supports for photosensitizer formulations
JP2001348341A (ja) * 2000-06-06 2001-12-18 Terumo Corp 低酸素状態の細胞および組織に有効な人工酸素運搬体
US20050048109A1 (en) * 2003-08-26 2005-03-03 Ceramoptec Industries, Inc. Non-polar photosensitizer formulations for photodynamic therapy

Also Published As

Publication number Publication date
KR20080027974A (ko) 2008-03-28
ES2403601T3 (es) 2013-05-20
US20060088584A1 (en) 2006-04-27
CA2746516A1 (en) 2005-03-17
EP1660041A4 (en) 2010-01-27
WO2005023220A1 (en) 2005-03-17
US7354599B2 (en) 2008-04-08
KR20080110685A (ko) 2008-12-18
JP2007503436A (ja) 2007-02-22
IL173808A0 (en) 2006-07-05
RU2343904C2 (ru) 2009-01-20
KR100975160B1 (ko) 2010-08-10
PT1660041E (pt) 2013-05-15
AU2004270119B2 (en) 2008-06-05
JP4869929B2 (ja) 2012-02-08
HUE026790T2 (en) 2016-07-28
IL173808A (en) 2015-11-30
KR20060039451A (ko) 2006-05-08
IL203995A (en) 2017-05-29
KR100973064B1 (ko) 2010-08-17
US20060159740A1 (en) 2006-07-20
JP5639014B2 (ja) 2014-12-10
AU2004270119A1 (en) 2005-03-17
KR100887785B1 (ko) 2009-03-09
BRPI0413889A (pt) 2006-10-24
EP1660041A1 (en) 2006-05-31
RU2006109497A (ru) 2007-10-10
CN1842322A (zh) 2006-10-04
JP2011213731A (ja) 2011-10-27
PL1660041T3 (pl) 2013-08-30
DK1660041T3 (da) 2013-06-03
CA2536977C (en) 2011-10-11
EP1660041B1 (en) 2013-03-06
US20050048109A1 (en) 2005-03-03
CA2746516C (en) 2013-05-07
DK2471512T3 (en) 2016-04-04
CA2536977A1 (en) 2005-03-17
EP2471512B1 (en) 2016-03-16
CN1842322B (zh) 2011-05-04
EP2471512A2 (en) 2012-07-04
ES2566681T3 (es) 2016-04-14
EP2471512A3 (en) 2012-07-11

Similar Documents

Publication Publication Date Title
PL2471512T3 (pl) Formulacje niepolarnych fotouczulaczy do terapii fotodynamicznej
CY2013022I1 (el) Συνθεσεις για την θεραπευτικη αγωγη γαστρεντερικων διαταραχων
CY2019030I2 (el) Παραγωγο ραπαμυκινης για την θεραπευτικη αντιμετωπιση του καρκινου του πνευμονα
IS8398A (is) Lyfjasamsetningar til að meðhöndla æxli
NO20044402L (no) Kombinasjonsbehandling av kemokine-medierte sykdommer
NO20053077D0 (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
CY2018006I2 (el) Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
CY2016035I1 (el) Θεραπευτικη χρηση αντισωματων anti-cs1
CY2015003I1 (el) Φαρμακευτικες συνθεσεις για θεραπεια καρκινου
NO20050426L (no) Arylkarbonylderivater som terapeutiske midler
DE60336485D1 (de) Kombinationstherapie gegen hyperproliferative erkrankungen
GB0520687D0 (en) Skin treatment formulations
IS7691A (is) Lyfjasamsetningar til að meðhöndla æxli
DE60315135D1 (de) Therapiesonde
EP1663157A4 (en) Stabilized phosphatidylserine formulations
GB0305150D0 (en) Use of therapeutic compounds
EP1701726A4 (en) Antimicrobial photodynamic therapy compound and method of use
AU2003272317A8 (en) Treatment of periodontal disease with photosensitizers
ITMI20031311A0 (it) Formulazioni per il trattamento di disturbi artrosici
IL175535A (en) Compositions for treatment of neurodegenerative diseases
ZA200707934B (en) Thereapeutic formulations for the treatment of beta-amyloid related diseases
ZA200705011B (en) Formulations of substituted benzoxazoles
AU2003224000A1 (en) Compounds useful as photodynamic therapeutic agents
AU2003301267A8 (en) Photodynamic therapy for ocular neovascularization
EP1740541A4 (en) THERAPEUTIC FORMULATIONS OF DESOXYEPOTHILONES